Loading clinical trials...

Comparison of Tolerability Between Two Allergy Drops | Clinical Trials | Clareo Health

UNKNOWNPHASE4

Comparison of Tolerability Between Two Allergy Drops

NCT01390961•Hom, Milton M., OD, FAAO

View on ClinicalTrials.gov

Summary

Comfort is compared between two allergy drops

Eligibility

Age

1 - No limit years

Sex

ALL

Healthy Volunteers

Yes

Inclusion Criteria

•Between the ages of 18 and over inclusive.
•Males or females
•Patient is in generally good \& stable overall health.
•Patient likely to comply with study guidelines \& study visits.
•Informed consent signed.
•History of allergic conjunctivitis
•Current symptoms of allergic conjunctivitis assessed by the investigator

Exclusion Criteria

•Corneal refractive surgery or contact lens wear within 6 months of this study.
•Current use of Restasis
•Intra-ocular surgery within 6 months or ocular laser surgery within 6 months.
•Pregnant or lactating women.
•Ocular pathology (includes glaucoma and cataract), which could impact results and/or place patient at risk.

Locations (1)

Milton M. Hom, OD, FAAO.

Azusa, California, United States

Key Dates

Start Date

August 1, 2011

Primary Completion Date

December 1, 2011

Completion Date

January 1, 2012

Last Updated

July 11, 2011

Enrollment

ESTIMATED participants

Conditions

Allergic Conjunctivitis

Interventions

alacaftadine and naphazoline HCl & pheniramine maleate

DRUG

The Role of Vitamin D in Corneal Epithelial Barrier Function, Ocular Microbiome, Ocular Inflammation, and Visual Acuity of Children With Allergic Conjunctivitis

NCT05839938

Allergic Conjunctivitis

View study

ACTIVE_NOT_RECRUITING

Tyrosine Allergoid Paediatric and Adult Study

NCT05186025

Allergic Rhinitis Due to PollenAllergic Conjunctivitis+1 more

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: July 11, 2011Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Comparison of Tolerability Between Two Allergy Drops

Inclusion Criteria

Exclusion Criteria

The Role of Vitamin D in Corneal Epithelial Barrier Function, Ocular Microbiome, Ocular Inflammation, and Visual Acuity of Children With Allergic Conjunctivitis

Tyrosine Allergoid Paediatric and Adult Study

Documentation of Efficacy of Intralymphatic Allergen Immunotherapy

Clinical and Biological Evaluation of NAAGA Versus Azelastine Eye Drops in Allergic Subjects With Tear Film Dysfunction

Evaluation of Brimonidine Tartrate/Ketotifen Fumarate Combination for the Treatment of Allergic Conjunctivitis

Dietary Choice for the Management of Cow's Milk Allergy Influences Other Allergic Manifestations